A novel algorithm to improve pathologic stage prediction of clinically organ-confined muscle-invasive bladder cancer

Cancer

Volumn 115, Issue 7, 2009, Pages 1459-1464

  Margel, D ^a   Harel, Amir ^a   Yossepowitch, Ofer ^a,b   Baniel, Jack ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CA 125; CA 19 9; Carcinoembryonic antigen; Mathematical prediction model; Tumor markers; Urothelial carcinoma

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ALGORITHM; ARTICLE; BLADDER CANCER; CALCULATION; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; EXTERNAL VALIDITY; FEMALE; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS; TUMOR VOLUME; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS;

EID: 63449107172     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24138     Document Type: Article

References (18)

1. David KA, Milowsky MI, Ritchey J, et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol. 1997;178:451-455.
2. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today: a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21:690- 695.
3. Herr HW, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177:437-441.
4. Margel D, Tal R, Neuman A, Konichezky M, Sella A, Baniel J. Prediction of extravesical disease by preoperative serum markers in patients with clinically organ confined invasive bladder cancer. J Urol. 2006;175:1253-1258.
5. Margel D, Tal R, Baniel J. Serum tumor markers may predict overall and disease-specific survival in patients with clinically organ-confined invasive bladder cancer. J Urol. 2007;178:2297-2233.
6. Jiminez VK, Marshal FF. Surgery of bladder cancer. In: Walsh PC, Retik AB, eds. Campbell's Urology. 8th ed. Philadelphia: WB Saunders; 2002:2819-2844.
7. Fukunaga K. Introduction to statistical pattern recognition. In: Computer Science and Scientific Computing. 2nd ed. New York: Academic Press; 1990:399-417.
8. Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoper- ative application in prostate cancer. Curr Opin Urol. 2003;13:111-118.
9. Shen YJ, Huang SG. Improve survival prediction using principal components of gene expression data. Genomics Proteomics Bioinformatics. 2006;4:110-116.
10. Bonifazzi C, Cinti MN, Vincentis GD, et al. Principal component analysis of scintimammographic images. Phys Med. 2006;21(suppl 1):91-97.
11. Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma. Cancer. 2002;95:1451-1456.
12. Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA. 2006;295:299-305.
13. Quek ML, Sanderson K, Daneshmand S, Stein JP. New molecular markers for bladder cancer detection. Curr Opin Urol. 2004;14:259-266.
14. Chatterjee SJ, Datar R, Youssefzadeh D, et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol. 2004;22:1007-1012.
15. Shariat SF, Tokunaga H, Zhou J, et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol. 2004;22:1014-1021.
16. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Precystec- tomy nomogram for prediction of advanced bladder cancer stage. Eur Urol. 2006;50:1254-1259.
17. Quek ML, Stein JP, Nichols PW, et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol. 2005;174:103-106.
18. Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM. The p53 tumor suppressor gene and nuclear protein (basic science review and relevance in the management of bladder cancer). J Urol. 2003;169:1219-1225.